about
Thyroid Hormones, Oxidative Stress, and InflammationIncreased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration.Comparison of plasma antioxidant levels in middle-aged and old male with idiopatic osteoporosis: preliminary data.Biochemical alterations in semen of varicocele patients: a review of the literatureEstrogens as antioxidant modulators in human fertility.Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases.New developments in anthracycline-induced cardiotoxicity.Anthracyclines and mitochondria.Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.Plasmatic and Intracellular Markers of Oxidative Stress in Normal Weight and Obese Patients with Polycystic Ovary Syndrome.Oxidative stress and metabolic syndrome: Effects of a natural antioxidants enriched diet on insulin resistance.Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity.Thyroid Function and its Implications in Oxidative Stress Influencing the Pathogenesis of Osteoporosis in Adults with Down Syndrome: A Cohort Study.Human parathyroid hormone-related protein and human parathyroid hormone receptor type 1 are expressed in human medulloblastomas and regulate cell proliferation and apoptosis in medulloblastoma-derived cell lines.Evaluation of antioxidant systems in pituitary-adrenal axis diseases.Accumulation of essential oils in relation to root differentiation in Angelica archangelica L.Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications.Chalcone dimethylallyltransferase from Morus nigra cell cultures. Substrate specificity studies.Hormonal regulation of total antioxidant capacity in seminal plasma.Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion.Effects of testosterone on antioxidant systems in male secondary hypogonadism.Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome.The Role of Selenium in Oxidative Stress and in Nonthyroidal Illness Syndrome (NTIS): an overview.Frailty of Obese Children: Evaluation of Plasma Antioxidant Capacity in Pediatric Obesity.Effects of alkaloid precursor feeding on a Camptotheca acuminata cell lineGinsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactionsTriterpenoids and ellagic acid derivatives from in vitro cultures of Camptotheca acuminata DecaisneCirculating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot studyChalcone inhibition of anthracycline secondary alcohol metabolite formation in rabbit and human heart cytosolIncreased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysisInhibition of Anthracycline Alcohol Metabolite Formation in Human Heart Cytosol: A Potential Role for Several Promising DrugsCoenzyme Q10 supplementation in infertile men with low-grade varicocele: an open, uncontrolled pilot studyRelationships Between Thyroid Hormones, Insulin-Like Growth Factor-1 and Antioxidant Levels in Hypothalamic Amenorrhea and Impact on Bone MetabolismAnabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant CapacityIs There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism?
P50
Q26751365-0BC253C3-F83C-4665-949B-56DCA36E51A1Q30829971-3A6027F7-9809-4271-9D3E-FA5CAB1BBC0EQ30836609-E21A6F76-21CE-431E-B647-7E91D87C2354Q35207882-2EDCE857-7092-4923-B3C8-558C7F733F74Q37393591-917AFADB-731E-4138-9E44-AB62FD275310Q37420907-3F5ACE12-63D7-4E36-B7DC-DC229193FBAFQ37481832-18DCFD1C-C3A1-4A12-98EC-DC6893FED1EAQ37991646-A405ADD8-1052-436E-8748-C22236A2358AQ38623640-FD42E9F9-66E2-4C60-8B44-588F2D292278Q38694312-4D97868A-AA90-4800-89BD-C34565883B65Q38770958-D4725C37-E024-4B9B-B084-1DB360D3FBDFQ39039393-109D5A4E-37E0-4661-878B-23024F39126DQ39457421-F6ECFD79-09B8-4341-B8E2-8A14C342FD5BQ40156814-61CF3140-A37F-4C47-B473-832671EBD87DQ43220212-194DC4DC-A0D4-4F49-BA74-ED80B9E4086BQ44396950-B735174B-8838-48CD-9F7F-A35485E9CAF5Q44578142-D2BA6A01-2235-469C-8CEE-EA7231A9C1ABQ44740746-EBA2F263-C128-4000-9FC7-01D08EC2E5C0Q46113803-E794DFCF-78F7-4F5A-8902-7B22E0CECC95Q46270263-A8693245-E48D-4768-BBF1-305E099EFB7DQ46473089-16D503DD-D487-44C6-9821-13A9849DF9F3Q47588764-E3E04AC5-EFA3-4173-924C-449BBDEBA4F9Q50109409-6C0D498D-E29C-4837-BFDF-D9CDF8E0C6AAQ53103004-4B5C5AC1-1C0F-4E1D-AA0A-DEFB1D5E40A3Q57058211-9631E7FC-396D-441A-9191-6005DAB8530FQ58553347-60CEFF90-DA07-4551-BE8A-CFD30AE737C8Q60360364-AB12F91B-2D1C-4B02-9F89-C4EB67E600D0Q61446606-E653B897-6D50-4008-A522-ADF0F69DEDE1Q79367838-7BEBA2A5-7E9E-4C97-B1B5-FAC346F1B8C7Q79962922-B7AE5D41-61F9-41F8-BD98-F39895393C41Q85892584-F9DFD7ED-D462-4D55-BE20-E6323E73BDF5Q87289548-35765AD7-1890-4DD3-A685-C2F0814F7ADFQ92215453-BB8178A3-22FC-4491-ABE7-1D0623805830Q94922556-8605D9E1-13CF-494F-AC12-3E3579248D20Q94922571-DD88496C-83E2-47C1-8A94-2B2DF2BAC21E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea Silvestrini
@ast
Andrea Silvestrini
@en
Andrea Silvestrini
@es
Andrea Silvestrini
@nl
Andrea Silvestrini
@sl
type
label
Andrea Silvestrini
@ast
Andrea Silvestrini
@en
Andrea Silvestrini
@es
Andrea Silvestrini
@nl
Andrea Silvestrini
@sl
altLabel
Andrea
@en
prefLabel
Andrea Silvestrini
@ast
Andrea Silvestrini
@en
Andrea Silvestrini
@es
Andrea Silvestrini
@nl
Andrea Silvestrini
@sl
P1053
B-3410-2009
P106
P1153
57191632443
6603387417
P31
P3829
P496
0000-0002-2005-3746